Bivium Biosciences offers a compelling investment opportunity in neurodegenerative medicine. Leveraging key scientific discoveries made by our group, we are developing a highly differentiated therapeutic approach that promises to revolutionize how we approach treating neurodegenerative diseases like Multiple Sclerosis and Alzheimer’s Disease.
Corporate Overview Presentation
Download a PDF of our corporate overview and get an in-depth look at our company’s mission, therapeutic approach, leadership, and future plans.
Invest in Bivium
Click the link below to be redirected to our company insights and get started towards becoming a part of our investor community.
Recent work by our group has identified two novel therapeutic entry points within the neurodegenerative cascade, enabling the precise and strategic targeting of the root causes of neuronal damage and neurodegeneration.
While current treatments focus on indirectly suppressing disease progression, our novel insights allow us to directly block key drivers of the pathology.
Our Novel Approach
Dive into our novel insights and discover our innovative therapeutic approach.